Creso was quoted in the story With key tax credit under microscope, biotech firms say it should stay, be improved. The article discusses the SR&ED program from the perspective of biotech companies. Excerpt:
Creso Sá, a professor with the University of Toronto’s Centre for the Study of Canadian and International Higher Education, isn’t a fan of SR&ED, noting its size, complexity, and lack of measurable impact. He said comparable economies generally have a mix of direct and indirect support… [Read full article]
Creso Sá 